Randomized Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients - Tabular View

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

Randomized Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients

This study has been completed.

Study NCT00175175. Last updated on September 13, 2006. Information provided by University of Alberta

This Tabular View shows the required WHO registration data elements as marked by ^†

Descriptive Information Fields

Brief Title ^†

Randomized Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients

Official Title ^†

Randomized Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients

Brief Summary

Patients with hip fractures have suffered the most devastating consequence of osteoporosis; and yet, they are rarely if ever tested or treated for the condition, even though they remain at high risk of recurrent fracture.

We hypothesize that, compared with usual care, an allied health professional-run osteoporosis service (case management) will be able to increase testing and treatment of osteoporosis in patients at high risk of fracture.

Detailed Description

Study Phase

Study Type ^†

Interventional

Study Design ^†

Treatment, Randomized, Single Blind, Active Control, Parallel Assignment, Safety/Efficacy Study

Primary Outcome Measure ^†

The proportion of patients taking bisphosphonate therapy within 6 months of hip fracture

Secondary Outcome Measure ^†

Proportion of patients taking prescription osteoporosis treatment at 6 months and 12 months
Proportion in receipt of a BMD test at 6 months and 12 months
Proportion still adherent to osteoporosis treatments at 6 months and 12 months
Proportion of patients with recurrent fractures at 6 months and 12 months
Cost effectiveness analyses

Condition ^†

Osteoporosis
Hip Fracture

Intervention ^†

Behavioral: Allied health professional-run osteoporosis service ("case-management")

MEDLINE PMIDs

Links

Recruitment Information Fields

Recruitment Status ^†

Completed

Enrollment ^†

220

Start Date ^†

March 2002

Completion Date

Eligibility Criteria ^†

Inclusion Criteria:

hip fracture patient > 50 years of age
able to give consent (or proxy consent available)
lives within health region
no contraindications to bisphosphonate therapy

Exclusion Criteria:

refuses to participate or consent
dementia or delirium without a proxy consent available
nursing home or longterm care
pathologic fracture
chronic glucocorticoid use
already receiving prescription osteoporosis treatment (calcium and vitamin D do not preclude inclusion)

Gender

Both

Ages

50 Years and older

Accepts Healthy Volunteers

Contacts ^††

Location Countries ^†

Canada

Administrative Information Fields

NCT ID ^†

NCT00175175

Organization ID

AHFMR #200100791

Secondary IDs ^††

Study Sponsor ^†

University of Alberta

Collaborators ^††

Alberta Heritage Foundation for Medical Research
Royal Alexandra Hospital

Investigators ^†

Principal Investigator:

Sumit R Majumdar, MD, MPH

University of Alberta

Information Provided By

University of Alberta

Verification Date

September 2006

First Received Date ^†

September 9, 2005

Last Updated Date

September 13, 2006

^† Required WHO trial registration data element.
^†† WHO trial registration data element that is required only if it exists.